The scavenger receptor CD36 contributes to the neurotoxicity of bone marrow-derived monocytes through peroxynitrite production

Neurobiology of Disease

Volumn 42, Issue 3, 2011, Pages 292-299

  Zhou, Ping ^a   Qian, Liping ^a   Gallo, Eduardo F ^a   Deeb, Ruba S ^a   Anrather, Josef ^a   Gross, Steven S ^a   Iadecola, Costantino ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Bone marrow derived monocytes macrophages; CD36; Hippocampal slice; Oxidative and nitrative stress

Indexed keywords

3 NITROTYROSINE; 5,10,15,20 TETRAKIS(4 SULFONATOPHENYL)PORPHYRINATO IRON CHLORIDE; CD36 ANTIGEN; GLUCOSE; MANGANESE TETRAKIS(4 BENZOIC ACID)PORPHYRIN CHLORIDE; NITRATE; NITRITE; OXYGEN; PEROXYNITRITE; PORPHYRIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BRAIN DAMAGE; BRAIN ISCHEMIA; BRAIN SLICE; CELL INFILTRATION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE MODEL; HIPPOCAMPUS; INFLAMMATORY CELL; KNOCKOUT GENE; MACROPHAGE; MONOCYTE; MOUSE; NEUROTOXICITY; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; ANTIGENS, CD36; BONE MARROW; FLOW CYTOMETRY; GLUCOSE; HIPPOCAMPUS; MICE; MICE, KNOCKOUT; MONOCYTES; PEROXYNITROUS ACID; REACTIVE OXYGEN SPECIES;

EID: 79954632593     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.01.019     Document Type: Article

References (41)

1. Abe T., Shimamura M., Jackman K., Kurinami H., Anrather J., Zhou P., Iadecola C. Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia. Stroke 2010, 41:898-904.
2. Akashi-Takamura S., Miyake K. TLR accessory molecules. Curr. Opin. Immunol. 2008, 20:420-425.
3. Austin P.E., McCulloch E.A., Till J.E. Characterization of the factor in L-cell conditioned medium capable of stimulating colony formation by mouse marrow cells in culture. J. Cell. Physiol. 1971, 77:121-134.
4. Benov L., Sztejnberg L., Fridovich I. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic. Biol. Med. 1998, 25:826-831.
5. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
6. Brown G.C., Neher J.J. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol. Neurobiol. 2010, 41:242-247.
7. Cho S., Park E.M., Febbraio M., Anrather J., Park L., Racchumi G., Silverstein R.L., Iadecola C. The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. J. Neurosci. 2005, 25:2504-2512.
8. del Zoppo G.J., Milner R., Mabuchi T., Hung S., Wang X., Berg G.I., Koziol J.A. Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 2007, 38:646-651.
9. Duport S., Garthwaite J. Pathological consequences of inducible nitric oxide synthase expression in hippocampal slice cultures. Neuroscience 2005, 135:1155-1166.
10. Felger J.C., Abe T., Kaunzner U.W., Gottfried-Blackmore A., Gal-Toth J., McEwen B.S., Iadecola C., Bulloch K. Brain dendritic cells in ischemic stroke: time course, activation state, and origin. Brain Behav. Immun. 2010, 24:724-737.
11. Furuya K., Takeda H., Azhar S., McCarron R.M., Chen Y., Ruetzler C.A., Wolcott K.M., DeGraba T.J., Rothlein R., Hugli T.E., del Zoppo G.J., Hallenbeck J.M. Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study. Stroke 2001, 32:2665-2674.
12. Gelderblom M., Leypoldt F., Steinbach K., Behrens D., Choe C.U., Siler D.A., Arumugam T.V., Orthey E., Gerloff C., Tolosa E., Magnus T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857.
13. Grisham M.B., Johnson G.G., Lancaster J.R. Quantitation of nitrate and nitrite in extracellular fluids. Meth. Enzymol. 1996, 268:237-246.
14. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., Sovath S., Shamel L., Hartung T., Zahringer U., Beutler B. CD36 is a sensor of diacylglycerides. Nature 2005, 433:523-527.
15. Hooper C., Fry V.A., Sevastou I.G., Pocock J.M. Scavenger receptor control of chromogranin A-induced microglial stress and neurotoxic cascades. FEBS Lett. 2009, 583:3461-3466.
16. Hyman M.C., Petrovic-Djergovic D., Visovatti S.H., Liao H., Yanamadala S., Bouis D., Su E.J., Lawrence D.A., Broekman M.J., Marcus A.J., Pinsky D.J. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J. Clin. Invest. 2009, 119:1136-1149.
17. Hallenbeck J., Del Zoppo G., Jacobs T., Hakim A., Goldman S., Utz U., Hasan A. Immunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary. Stroke 2006, 37:3035-3042.
18. Iadecola C. Bone marrow spawns brain killers. Nat. Med. 2004, 10:1044-1045.
19. Iadecola C., Cho S., Feuerstein G.Z., Hallenbeck J. Cerebral Ischemia and Inflammation 2004, 883-894. Churchill Livingstone, New York.
20. Kawano T., Anrather J., Zhou P., Park L., Wang G., Frys K.A., Kunz A., Cho S., Orio M., Iadecola C. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat. Med. 2006, 12:225-229.
21. Kim Y., Zhou P., Qian L., Chuang J.Z., Lee J., Li C., Iadecola C., Nathan C., Ding A. MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival. J. Exp. Med. 2007, 204:2063-2074.
22. Kunz A., Abe T., Hochrainer K., Shimamura M., Anrather J., Racchumi G., Zhou P., Iadecola C. Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion. J. Neurosci. 2008, 28:1649-1658.
23. Lakhan S.E., Kirchgessner A., Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 2009, 7:97-108.
24. Mabuchi T., Kitagawa K., Ohtsuki T., Kuwabara K., Yagita Y., Yanagihara T., Hori M., Matsumoto M. Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 2000, 31:1735-1743.
25. Mander P., Brown G.C. Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration. J. Neuroinflammation 2005, 2:20-35.
26. Moore K.J., El Khoury J., Medeiros L.A., Terada K., Geula C., Luster A.D., Freeman M.W. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J. Biol. Chem. 2002, 277:47373-47379.
27. Moskowitz M.A., Lo E.H., Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010, 67:181-198.
28. Muller D., Toni N., Buchs P., Parisi L., Stoppini L. Interface organotypic hippocampal slice cultures. Protocols for Neural Cell Culture 2001, 13-27. Humana Press. 3rd Edition. S. Fedoroff, A. Richardson (Eds.).
29. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.
30. Nuriel T., Deeb R.S., Hajjar D.P., Gross S.S. Protein 3-nitrotyrosine in complex biological samples: quantification by high-pressure liquid chromatography/electrochemical detection and emergence of proteomic approaches for unbiased identification of modification sites. Meth. Enzymol. 2008, 441:1-17.
31. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
32. Perry V.H., Nicoll J.A., Holmes C. Microglia in neurodegenerative disease. Nat. Rev. Neurol. 2010, 6:193-201.
33. Schilling M., Besselmann M., Leonhard C., Mueller M., Ringelstein E.B., Kiefer R. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp. Neurol. 2003, 183:25-33.
34. Shichita T., Sugiyama Y., Ooboshi H., Sugimori H., Nakagawa R., Takada I., Iwaki T., Okada Y., Iida M., Cua D.J., Iwakura Y., Yoshimura A. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat. Med. 2009, 15:946-950.
35. Silverstein R.L., Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal. 2009, 2(re3).
36. Sughrue M.E., Mehra A., Connolly E.S., D'Ambrosio A.L. Anti-adhesion molecule strategies as potential neuroprotective agents in cerebral ischemia: a critical review of the literature. Inflamm. Res. 2004, 53:497-508.
37. Tanaka R., Komine-Kobayashi M., Mochizuki H., Yamada M., Furuya T., Migita M., Shimada T., Mizuno Y., Urabe T. Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia. Neuroscience 2003, 117:531-539.
38. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 2007, 184:53-68.
39. Yin F., Banerjee R., Thomas B., Zhou P., Qian L., Jia T., Ma X., Ma Y., Iadecola C., Beal M.F., Nathan C., Ding A. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J. Exp. Med. 2010, 207:117-128.
40. Zhang X., Goncalves R., Mosser D.M. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 2008, 14:14.1.1.
41. Zhao X., Sun G., Zhang J., Strong R., Song W., Gonzales N., Grotta J.C., Aronowski J. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann. Neurol. 2007, 61:352-362.